Novavax’s COVID-19 vaccine 96.4 per cent effective against virus in phase-3 trial
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
While a big war is being waged in the Middle East, global attention has moved away from another theatre of...
Read moreDetails
Fuel has been a long-time great economic and political tool in the hands of the government in India. It enables...
Read moreDetails
Consider this thought experiment. Imagine that two large missiles struck the White House. The first hit the residential quarters at...
Read moreDetails
The news that a clutch of Bihar’s senior babus may soon head to Delhi on Central deputation, in the wake...
Read moreDetails